Author:
Masoudi Melika,Tashakor Amirhossein,Mansury Davood
Abstract
Recently, there have been various chemical carriers and routines for treatment of infections. Plant gum nanoparticles are being used greatly for this purpose. They have several advantages over chemical drug carriers including being biodegradable, biocompatible, nontoxic, providing better tolerance to the patient, and having fewer side effects. They also do not cause allergies in humans, do not irritate the skin or eyes, and have low production costs. The use of plant gums as drug carriers is limited due to a series of disadvantages. They may have microbial contamination because of the moisture in their content. Also, in storage, their viscosity decreases due to contact with water. By green nanoparticle synthesis of these plant gums as drug carriers, the disadvantages can be limited. There are several studies showing that plant gum drug carriers can have a great combination with various drugs and nanoparticles, thus they could be extremely effective against multi-resistant bacteria and even systemic illness like cancer. These days, the need for green synthesis of medicine and drug carriers has become quite popular and it will be even more essential in the future because of emerging antibiotic-resistant bacteria and climate change.
Reference32 articles.
1. Khan I, Saeed K, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry. 2019;12(7):908-931
2. Islam NU, Amin R, Shahid M, Amin M, Zaib S, Iqbal J. A multi-target therapeutic potential of Prunusdomestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties. BMC Complementary and Alternative Medicine. 2017;17(1):1-17
3. Abulafatih H. Medicinal plants in southwestern Saudi Arabia. Economic Botany. 1987;41(3):354-360
4. Siddiqui AH, Koirala J. Methicillin Resistant Staphylococcus aureus. Europe: StatPearls; 2020
5. Levitus M, Rewane A, Perera TB. Vancomycin-Resistant Enterococci (VRE). Europe: StatPearls; 2020